Docetaxel in Treating Patients With Relapsed Prostate Cancer

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with relapsed prostate cancer.

Timeline

Start

2007-05

Primary completion

2009-07

Completion

2009-07

Outcome

Outcome not reported

Stopped (Business): “Drug supplier stopped funding due to loss of study drug (docetaxel) patent.”

Drugs

Indications